© 2022 MJH Life Sciences™ and Contemporary OB/GYN. All rights reserved.
Genevieve Neal-Perry, MD, PhD, sits down with Contemporary OB/GYN to discuss positive data from a recent phase 3 study evaluating fezolinetant (Astellas) for vasomotor symptoms (VMS).